|4Apr 7, 4:52 PM ET

CUMBERLAND PHARMACEUTICALS INC 4

4 · CUMBERLAND PHARMACEUTICALS INC · Filed Apr 7, 2017

Insider Transaction Report

Form 4
Period: 2017-04-07
Bonner Michael
Chief Financial Officer
Transactions
  • Tax Payment

    Common Stock

    2017-04-07$6.45/sh653$4,21214,647 total
  • Award

    Common Stock

    2017-04-07$6.45/sh+2,500$16,12515,300 total
Footnotes (2)
  • [F1]Restricted stock award will vest 100% on March 17, 2021.
  • [F2]This transaction represents shares withheld by the Company to cover the tax withholding obligations for the vesting of 2,000 shares during March 2017.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION